1921
Volume 96, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0888
2017-01-11
2017-09-26
Loading full text...

Full text loading...

/deliver/fulltext/14761645/96/1/9.html?itemId=/content/journals/10.4269/ajtmh.16-0888&mimeType=html&fmt=ahah

References

  1. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, , 2007. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis 7: 93104.[Crossref]
  2. Garner P, Gulmezoglu A, , 2006. Drugs for preventing malaria in pregnant women. Cochrane Database Syst Rev 4: CD000169.
  3. World Health Organization (WHO), 2004. A Strategic Framework for Malaria Prevention and Control during Pregnancy in the Africa Region. Vol. AFR/MAL/04/01, Brazzaville, Africa: WHO Regional Office for Africa.
  4. Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, Hutchinson P, Steketee RW, , 2012. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis 12: 942949.[Crossref]
  5. Desai M, Gutman J, Taylor SM, Wiegand RE, Khairallah C, Kayentao K, Ouma P, Coulibaly SO, Kalilani L, Mace KE, Arinaitwe E, Mathanga DP, Doumbo O, Otieno K, Edgar D, Chaluluka E, Kamuliwo M, Ades V, Skarbinski J, Shi YP, Magnussen P, Meshnick S, Ter Kuile FO, , 2016. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for malaria in pregnancy at clearing infections and preventing low birth weight. Clin Infect Dis 62: 323333.[Crossref]
  6. Desai M, Gutman J, L'Lanziva A, Otieno K, Juma E, Kariuki S, Ouma P, Were V, Laserson K, Katana A, Williamson J, Ter Kuile FO, , 2015. Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial. Lancet 386: 25072519.[Crossref]
  7. Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, Opira B, Olwoch P, Ategeka J, Nayebare P, Clark TD, Feeney ME, Charlebois ED, Rizzuto G, Muehlenbachs A, Havlir DV, Kamya MR, Dorsey G, , 2016. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 374: 928939.[Crossref]
  8. Stoner M, Smid M, Kumwenda A, Stringer E, Chi B, Stringer J, , 2017. Dosage of sulfadoxine-pyrimethamine and risk of low birth weight in a cohort of Zambian pregnant women in a low malaria prevalence region. Am J Trop Med Hyg 96: 170177.[Crossref]
  9. Klement E, Pitché P, Kendjo E, Singo A, D'Almeida S, Akouete F, Akpaloo Y, Tossa K, Prince-Agbodjan S, Patassi A, Caumes E, , 2014. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial. Clin Infect Dis 58: 651659.[Crossref]
  10. Gonzalez R, Desai M, Macete E, Ouma P, Kakolwa MA, Abdulla S, Aponte JJ, Bulo H, Kabanywanyi AM, Katana A, Maculuve S, Mayor A, Nhacolo A, Otieno K, Pahlavan G, Ruperez M, Sevene E, Slutsker L, Vala A, Williamsom J, Menendez C, , 2014. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial. PLoS Med 11: e1001735.[Crossref]
  11. Dingens A, Fairfortune TS, Reed S, Mitchell C, , 2016. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth 16: 278.[Crossref]
  12. Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ, , 2013. Infant antibiotic exposures and early-life body mass. Int J Obes 37: 1623.[Crossref]
  13. Cho I, Yamanishi S, Cox L, Methé BA, Zavadil J, Li K, Gao Z, Mahana D, Raju K, Teitler I, Li H, Alekseyenko AV, Blaser MJ, , 2012. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 488: 621626.[Crossref]
  14. Capan M, Mombo-Ngoma G, Makristathis A, Ramharter M, , 2010. Anti-bacterial activity of intermittent preventive treatment of malaria in pregnancy: comparative in vitro study of sulphadoxine-pyrimethamine, mefloquine, and azithromycin. Malar J 9: 303.[Crossref]
  15. Moodley T, Moodley D, Sebitloane M, Maharaj N, Sartorius B, , 2016. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa. BMC Pregnancy Childbirth 16: 35.[Crossref]
  16. Mofeson L, , 2015. Antiretroviral therapy and adverse pregnancy outcome: the elephant in the room? J Infect Dis 213: 10511054.[Crossref]
  17. Li N, Sando M, Spiegelman D, Hertzmark E, Liu E, Sando D, Machumi L, Chalamilla G, Fawzi W, , 2016. Antiretroviral therapy in relation to birth outcomes among HIV-infected women: a cohort study. J Infect Dis 213: 10571064.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0888
Loading
  • Received : 09 Nov 2016
  • Accepted : 11 Nov 2016

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error